Jennifer R Rose-Nussbaumer, MD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rose-Nussbaumer’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A121301 · Current
Licensed to practise in California · since 2012 · expires 2027-08-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$95,401
Medicare paid this office $95,401 for 263 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 203 | $23,384 | $55 |
| Removal of cataract with insertion of prosthetic lens | 27 | $17,113 | $503 |
| Transplantation of outer layer of corneal tissue | 14 | $15,786 | $1,128 |
| New patient visit (30+ min) | 64 | $4,390 | $69 |
| Closure of tear duct opening using plug | 22 | $4,089 | $128 |
See all 10 services
| Short return visit (20+ min) | 203 | $23,384 | $55 |
| Removal of cataract with insertion of prosthetic lens | 27 | $17,113 | $503 |
| Transplantation of outer layer of corneal tissue | 14 | $15,786 | $1,128 |
| New patient visit (30+ min) | 64 | $4,390 | $69 |
| Closure of tear duct opening using plug | 22 | $4,089 | $128 |
| Ct scan of cornea | 74 | $1,782 | $17 |
| Imaging of retina | 63 | $1,647 | $22 |
| Measurement of corneal curvature and depth of eye | 40 | $1,137 | $28 |
| Imaging of front third of eye using a special microscope | 30 | $675 | $19 |
| Photography of content of eyes | 30 | $91 | $2 |
Procedures Medicare counted
| Cataract surgery | 76 | More than 70% of doctors who do this |
Who their Medicare patients are
263 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 11% · Women 63% · Also on Medicaid 35% · Health risk score 1.13. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 65% · Diabetes 28% · Coronary heart disease 23% · Chronic kidney disease 18% · Depression 18% · Atrial fibrillation 16% · Cancer 14% · Heart failure 13% · COPD 8% · Stroke 8% · Dementia 5%.
The office billed $612,663, Medicare allowed $123,725 and paid $95,401; for 960 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 263 | 960 | 75 | 1.13 | $612,663 | $95,401 |
| 2023 | 272 | 950 | 75 | 1.27 | $581,291 | $93,725 |
| 2022 | 253 | 968 | 74 | 1.17 | $635,661 | $95,493 |
| 2021 | 61 | 156 | 75 | 1.13 | $67,739 | $13,011 |
| 2018 | 215 | 588 | 73 | 1.42 | $524,049 | $65,843 |
| 2017 | 237 | 646 | 73 | 1.42 | $610,639 | $83,186 |
| 2016 | 292 | 736 | 72 | 1.37 | $625,708 | $91,338 |
| 2015 | 199 | 585 | 72 | 1.44 | $474,869 | $66,241 |
| 2014 | 215 | 631 | 70 | 1.51 | $573,785 | $79,833 |
| 2013 | 203 | 357 | 71 | 1.32 | $216,232 | $24,338 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 212 | $23,555 | $56 |
| Removal of cataract with insertion of prosthetic lens | 34 | $22,180 | $504 |
| Transplantation of outer layer of corneal tissue | 11 | $13,612 | $1,134 |
| Removal of recurring cataract in lens capsule using a laser | 14 | $5,001 | $313 |
| New patient visit (30+ min) | 63 | $3,988 | $63 |
| Closure of tear duct opening using plug | 12 | $2,486 | $155 |
| Ct scan of cornea | 83 | $1,990 | $17 |
| Imaging of retina | 75 | $1,894 | $21 |
| Measurement of corneal curvature and depth of eye | 40 | $1,126 | $27 |
| Imaging of front third of eye using a special microscope | 32 | $594 | $19 |
| Photography of content of eyes | 17 | $69 | $3 |
2022: 9 services
| Removal of cataract with insertion of prosthetic lens | 42 | $29,759 | $504 |
| Short return visit (20+ min) | 165 | $19,614 | $55 |
| New patient visit (30+ min) | 108 | $6,654 | $62 |
| Imaging of retina | 99 | $2,832 | $22 |
| Closure of tear duct opening using plug | 15 | $2,723 | $160 |
| Ct scan of cornea | 95 | $1,895 | $16 |
| Measurement of corneal curvature and depth of eye | 46 | $1,266 | $27 |
| Imaging of front third of eye using a special microscope | 34 | $703 | $18 |
| Photography of content of eyes | 13 | $47 | $2 |
2021: 4 services
| Short return visit (20+ min) | 31 | $2,745 | $58 |
| New patient visit (30+ min) | 29 | $2,135 | $74 |
| Imaging of retina | 12 | $303 | $23 |
| Ct scan of cornea | 13 | $234 | $18 |
2018: 9 services
| Removal of cataract with insertion of prosthetic lens | 28 | $17,753 | $573 |
| Established patient complete exam of visual system | 136 | $12,653 | $64 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $7,779 | $707 |
| Established patient problem focused exam of visual system | 98 | $5,404 | $41 |
| Measurement of corneal curvature and depth of eye | 31 | $1,749 | $28 |
| New patient complete exam of visual system | 15 | $1,053 | $70 |
| Imaging of retina | 18 | $679 | $24 |
| Exam of visual field with extended testing | 19 | $459 | $24 |
| Imaging of optic nerve | 14 | $250 | $18 |
2017: 9 services
| Removal of cataract with insertion of prosthetic lens | 34 | $19,752 | $549 |
| Established patient complete exam of visual system | 157 | $12,688 | $62 |
| Established patient problem focused exam of visual system | 102 | $6,232 | $43 |
| New patient complete exam of visual system | 24 | $1,783 | $74 |
| Measurement of corneal curvature and depth of eye | 29 | $1,572 | $29 |
| Imaging of retina | 21 | $654 | $23 |
| Exam of visual field with extended testing | 14 | $428 | $24 |
| Imaging of optic nerve | 13 | $284 | $19 |
| Photography of content of eyes | 13 | $40 | $2 |
2016: 9 services
| Removal of cataract with insertion of prosthetic lens | 46 | $28,239 | $576 |
| Established patient complete exam of visual system | 173 | $17,604 | $66 |
| Established patient problem focused exam of visual system | 104 | $6,412 | $45 |
| New patient complete exam of visual system | 55 | $4,682 | $85 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,435 | $264 |
| Measurement of corneal curvature and depth of eye | 27 | $1,472 | $27 |
| Exam of visual field with extended testing | 23 | $681 | $26 |
| Imaging of retina | 18 | $675 | $26 |
| Imaging of optic nerve | 17 | $498 | $26 |
2015: 6 services
| Removal of cataract with insertion of prosthetic lens | 23 | $16,739 | $577 |
| Established patient complete exam of visual system | 110 | $11,885 | $64 |
| Established patient problem focused exam of visual system | 100 | $6,309 | $44 |
| New patient complete exam of visual system | 32 | $2,401 | $75 |
| Measurement of corneal curvature and depth of eye | 27 | $1,484 | $28 |
| Exam of visual field with extended testing | 14 | $389 | $26 |
2014: 5 services
| Established patient complete exam of visual system | 146 | $17,066 | $66 |
| Removal of cataract with insertion of prosthetic lens | 20 | $14,819 | $570 |
| Established patient problem focused exam of visual system | 97 | $7,715 | $46 |
| New patient complete exam of visual system | 37 | $2,848 | $77 |
| Measurement of corneal curvature and depth of eye | 12 | $355 | $30 |
2013: 5 services
| Established patient complete exam of visual system | 118 | $11,876 | $72 |
| Established patient problem focused exam of visual system | 78 | $4,916 | $48 |
| New patient complete exam of visual system | 17 | $1,528 | $90 |
| Measurement of corneal curvature and depth of eye | 13 | $373 | $29 |
| Ultrasound scan of cornea to determine thickness | 11 | $95 | $9 |
Medicaid work
$6,150 in 2024
Medicaid paid $6,150 for 217 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 191 | $5,764 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 26 | $386 |
| 2024 | 217 | 2 | 26 | $6,150 |
| 2023 | 269 | 4 | 29 | $4,816 |
| 2022 | 258 | 4 | 20 | $6,665 |
| 2018 | 59 | 2 | 17 | $3,796 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 224 | $3,567 |
| New patient visit (30+ min) | 14 | $711 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 16 | $291 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 15 | $248 |
2022
| Short return visit (20+ min) | 175 | $3,610 |
| New patient visit (30+ min) | 43 | $2,293 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 27 | $556 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 13 | $206 |
2018
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 31 | $2,501 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 28 | $1,295 |
Drugs they prescribed that Part D paid
$61,559
Pharmacies billed $61,559 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
394 generic and 245 brand-name prescriptions · $61,559 in drug cost · 23 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 13 | $9,188 | $707 |
| Xiidra | 11 | $7,577 | $689 |
| Prednisolone Acetate | 134 | $7,427 | $55 |
| Valacyclovir | 51 | $5,035 | $99 |
| Cyclosporine | 19 | $4,003 | $211 |
See all 14 drugs
| Restasis | 13 | $9,188 | $707 |
| Xiidra | 11 | $7,577 | $689 |
| Prednisolone Acetate | 134 | $7,427 | $55 |
| Valacyclovir | 51 | $5,035 | $99 |
| Cyclosporine | 19 | $4,003 | $211 |
| Rhopressa | 12 | $3,396 | $283 |
| Dexamethasone Sodium Phosphate | 80 | $3,138 | $39 |
| Fluorometholone | 19 | $1,725 | $91 |
| Moxifloxacin | 48 | $1,180 | $25 |
| Polymyxin B Sul-Trimethoprim | 60 | $477 | $8 |
| Ketorolac Tromethamine | 11 | $306 | $28 |
| Latanoprost | 19 | $302 | $16 |
| Doxycycline Hyclate | 17 | $275 | $16 |
| Dorzolamide-Timolol | 20 | $201 | $10 |
Year by year
| 2024 | 639 | 164 | None | 38% | $61,559 |
| 2023 | 539 | 149 | None | 37% | $45,429 |
| 2022 | 553 | 182 | None | 42% | $51,681 |
| 2021 | 617 | 142 | None | 38% | $55,701 |
| 2020 | 687 | 143 | None | 41% | $58,880 |
| 2019 | 561 | 164 | None | 33% | $32,446 |
| 2018 | 552 | 113 | 0% (0) | None | $59,960 |
| 2017 | 452 | 105 | None | 59% | $70,975 |
| 2016 | 451 | 124 | None | 55% | $72,293 |
| 2015 | 420 | 98 | None | 55% | $45,844 |
| 2014 | 582 | 137 | None | 52% | $49,210 |
| 2013 | 725 | 194 | None | 57% | $74,987 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Prednisolone Acetate | 128 | $7,551 | $59 |
| Valacyclovir | 45 | $5,375 | $119 |
| Dexamethasone Sodium Phosphate | 59 | $2,785 | $47 |
| Fluorometholone | 13 | $1,554 | $120 |
| Moxifloxacin | 47 | $1,228 | $26 |
| Doxycycline Hyclate | 27 | $690 | $26 |
| Latanoprost | 21 | $375 | $18 |
| Dorzolamide-Timolol | 13 | $373 | $29 |
| Polymyxin B Sul-Trimethoprim | 34 | $325 | $10 |
| Brimonidine | 14 | $133 | $9 |
| Neomycin-Polymyxin-Dexameth | 12 | $115 | $10 |
| Prednisone | 11 | $101 | $9 |
2022: 12 drugs
| Xiidra | 14 | $9,543 | $682 |
| Prednisolone Acetate | 121 | $9,447 | $78 |
| Valacyclovir | 34 | $4,707 | $138 |
| Dexamethasone Sodium Phosphate | 60 | $2,671 | $45 |
| Fluorometholone | 21 | $2,329 | $111 |
| Doxycycline Hyclate | 21 | $1,215 | $58 |
| Moxifloxacin | 31 | $896 | $29 |
| Latanoprost | 36 | $524 | $15 |
| Polymyxin B Sul-Trimethoprim | 50 | $418 | $8 |
| Prednisone | 14 | $271 | $19 |
| Timolol Maleate | 11 | $177 | $16 |
| Neomycin-Polymyxin-Dexameth | 15 | $129 | $9 |
2021: 19 drugs
| Zioptan | 19 | $7,985 | $420 |
| Dorzolamide-Timolol | 20 | $6,784 | $339 |
| Prednisolone Acetate | 78 | $5,891 | $76 |
| Durezol | 14 | $2,971 | $212 |
| Valacyclovir | 41 | $2,870 | $70 |
| Phenylephrine | 30 | $2,090 | $70 |
| Fluorometholone | 23 | $2,074 | $90 |
| Intron A | 14 | $1,791 | $128 |
| Dexamethasone Sodium Phosphate | 42 | $1,660 | $40 |
| Moxifloxacin | 42 | $832 | $20 |
| Latanoprost | 40 | $690 | $17 |
| Dorzolamide-Timolol | 18 | $642 | $36 |
| Metronidazole | 14 | $574 | $41 |
| Polymyxin B Sul-Trimethoprim | 48 | $565 | $12 |
| Timolol Maleate | 19 | $452 | $24 |
| Olopatadine | 26 | $301 | $12 |
| Ofloxacin | 14 | $278 | $20 |
| Ketorolac Tromethamine | 11 | $264 | $24 |
| Brimonidine | 14 | $233 | $17 |
2020: 18 drugs
| Zioptan | 26 | $9,033 | $347 |
| Dorzolamide-Timolol | 49 | $8,382 | $171 |
| Zirgan | 18 | $7,611 | $423 |
| Prednisolone Acetate | 82 | $4,238 | $52 |
| Durezol | 17 | $3,387 | $199 |
| Blephamide | 11 | $3,351 | $305 |
| Valacyclovir | 31 | $2,293 | $74 |
| Dexamethasone Sodium Phosphate | 45 | $2,129 | $47 |
| Fluorometholone | 26 | $2,060 | $79 |
| Tacrolimus | 15 | $2,007 | $134 |
| Phenylephrine | 37 | $1,774 | $48 |
| Latanoprost | 41 | $892 | $22 |
| Polymyxin B Sul-Trimethoprim | 67 | $804 | $12 |
| Moxifloxacin | 45 | $751 | $17 |
| Olopatadine | 28 | $553 | $20 |
| Doxycycline Monohydrate | 11 | $497 | $45 |
| Timolol Maleate | 19 | $469 | $25 |
| Vancomycin | 20 | $35 | $2 |
2019: 16 drugs
| Prednisolone Acetate | 76 | $4,697 | $62 |
| Dexamethasone Sodium Phosphate | 56 | $3,017 | $54 |
| Valacyclovir | 39 | $2,513 | $64 |
| Blephamide S.O.P. | 14 | $2,283 | $163 |
| Durezol | 11 | $2,097 | $191 |
| Phenylephrine | 37 | $1,935 | $52 |
| Dorzolamide-Timolol | 11 | $1,851 | $168 |
| Fluorometholone | 16 | $1,307 | $82 |
| Gatifloxacin | 11 | $899 | $82 |
| Polymyxin B Sul-Trimethoprim | 65 | $743 | $11 |
| Vancomycin | 42 | $738 | $18 |
| Metronidazole | 15 | $471 | $31 |
| Latanoprost | 29 | $451 | $16 |
| Olopatadine | 20 | $398 | $20 |
| Moxifloxacin | 13 | $253 | $19 |
| Timolol Maleate | 11 | $237 | $22 |
2018: 12 drugs
| Combigan | 25 | $6,884 | $275 |
| Prednisolone Acetate | 104 | $6,205 | $60 |
| Durezol | 25 | $4,377 | $175 |
| Valacyclovir | 44 | $3,108 | $71 |
| Vancomycin | 68 | $2,290 | $34 |
| Famciclovir | 18 | $1,734 | $96 |
| Fluorometholone | 23 | $1,606 | $70 |
| Brimonidine | 14 | $1,504 | $107 |
| Moxifloxacin | 24 | $1,141 | $48 |
| Latanoprost | 43 | $561 | $13 |
| Polymyxin B Sul-Trimethoprim | 52 | $469 | $9 |
| Dorzolamide-Timolol | 11 | $278 | $25 |
2017: 13 drugs
| Valganciclovir | 12 | $31,025 | $2,585 |
| Durezol | 33 | $6,850 | $208 |
| Prednisolone Acetate | 88 | $4,904 | $56 |
| Brimonidine | 18 | $2,546 | $141 |
| Zioptan | 13 | $2,363 | $182 |
| Dexamethasone Sodium Phosphate | 13 | $1,955 | $150 |
| Alphagan P | 13 | $1,747 | $134 |
| Fluorometholone | 19 | $1,574 | $83 |
| Vancomycin | 36 | $1,409 | $39 |
| Dorzolamide-Timolol | 21 | $738 | $35 |
| Latanoprost | 44 | $618 | $14 |
| Acyclovir | 18 | $331 | $18 |
| Polymyxin B Sul-Trimethoprim | 35 | $285 | $8 |
2016: 11 drugs
| Valganciclovir | 12 | $34,347 | $2,862 |
| Durezol | 40 | $7,153 | $179 |
| Prednisolone Acetate | 75 | $5,625 | $75 |
| Alphagan P | 23 | $2,822 | $123 |
| Brimonidine | 19 | $2,614 | $138 |
| Vigamox | 15 | $2,405 | $160 |
| Fluorometholone | 23 | $2,022 | $88 |
| Valacyclovir | 11 | $1,029 | $94 |
| Dorzolamide-Timolol | 36 | $837 | $23 |
| Polymyxin B Sul-Trimethoprim | 53 | $435 | $8 |
| Latanoprost | 21 | $311 | $15 |
2015: 12 drugs
| Prednisolone Acetate | 91 | $7,623 | $84 |
| Valtrex | 11 | $4,787 | $435 |
| Vigamox | 23 | $3,702 | $161 |
| Lumigan | 11 | $2,842 | $258 |
| Durezol | 12 | $2,483 | $207 |
| Brimonidine | 18 | $2,185 | $121 |
| Alphagan P | 11 | $1,570 | $143 |
| Valacyclovir | 15 | $1,262 | $84 |
| Acyclovir | 31 | $597 | $19 |
| Dorzolamide-Timolol | 19 | $420 | $22 |
| Polymyxin B Sul-Trimethoprim | 45 | $411 | $9 |
| Timolol Maleate | 13 | $274 | $21 |
2014: 10 drugs
| Prednisolone Acetate | 168 | $15,380 | $92 |
| Vigamox | 34 | $4,220 | $124 |
| Valacyclovir | 30 | $4,196 | $140 |
| Doxycycline Hyclate | 18 | $3,371 | $187 |
| Brimonidine | 26 | $2,057 | $79 |
| Alphagan P | 21 | $2,044 | $97 |
| Dorzolamide-Timolol | 54 | $1,529 | $28 |
| Acyclovir | 25 | $1,072 | $43 |
| Polymyxin B Sul-Trimethoprim | 73 | $761 | $10 |
| Latanoprost | 16 | $396 | $25 |
2013: 17 drugs
| Travatan Z | 50 | $7,359 | $147 |
| Valacyclovir | 14 | $4,823 | $345 |
| Vigamox | 46 | $4,814 | $105 |
| Lumigan | 17 | $3,646 | $214 |
| Prednisolone Acetate | 114 | $3,609 | $32 |
| Brimonidine | 28 | $2,689 | $96 |
| Patanol | 17 | $2,338 | $138 |
| Pataday | 17 | $2,167 | $127 |
| Dorzolamide-Timolol | 40 | $1,314 | $33 |
| Acyclovir | 35 | $1,048 | $30 |
| Latanoprost | 33 | $915 | $28 |
| Acetazolamide | 23 | $772 | $34 |
| Polymyxin B Sul-Trimethoprim | 55 | $618 | $11 |
| Tropicamide | 16 | $342 | $21 |
| Fluorometholone | 18 | $263 | $15 |
| Ofloxacin | 12 | $146 | $12 |
| Timolol Maleate | 13 | $94 | $7 |
Money from drug and device companies
$339 in 2025
| 2025 | 4 | 4 | None | $339 |
| 2024 | 1 | 8 | None | $329 |
| 2023 | 2 | 4 | None | $499 |
| 2022 | 2 | 2 | None | $171 |
| 2021 | 2 | 2 | None | $224 |
| 2019 | 1 | 1 | None | $77 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech | Susvimo | $144 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $141 | 1 payment
|
| Alcon Vision | Clareon | $31 | 1 payment
|
| RxSight | Rxsight Injector Handpiece | $23 | 1 payment
|
See all 4 published payments
| Johnson & Johnson Surgical Vision | Meals · 2025-09-18 | Tecnis Simplicity | $141 |
| Genentech | Meals · 2025-07-17 | Susvimo | $144 |
| Alcon Vision | Meals · 2025-05-21 | Clareon | $31 |
| RxSight | Meals · 2025-04-18 | Rxsight Injector Handpiece | $23 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $329
| Alcon Vision | Clareon | $329 | 8 payments
|
2023: $499
| Alcon Vision | Clareon | $386 | 3 payments
|
| RxSight | Rxsight Contact Lens | $113 | 1 payment
|
2022: $171
| Alcon Vision | Clareon | $99 | 1 payment
|
| Carl Zeiss Meditec | None | $72 | 1 payment
|
2021: $224
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $123 | 1 payment
|
| Alcon Vision | Acrysof Iq Panoptix | $101 | 1 payment
|
2019: $77
| Carl Zeiss Meditec | Visumax | $77 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1598912859
- Licence
- CA A121301California A121301: Current · expires 2027-08-31
- Trained
- University of California, San Francisco School of Medicine, 2008
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207WX0120X (207WX0120X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-08-19
- NPI last updated
- 2024-04-04
- NPI record certified
- 2024-04-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 95 Kirkham St, San Francisco, CA, 94122